Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN64,1464,190,64
Msft0,97
Nokia3,9684,0290,81
IBM1,62
Mercedes-Benz Group AG62,2662,28-0,06
PFE1,01
31.08.2024 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 30.08.2024
Medifast (MED, NY Consolidated)
Závěr k 30.8.2024 Změna (%) Změna (USD) Objem obchodů (ks)
18,30 -1,61 -0,30 229 903
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti
Obecné informace
Název společnostiMedifast Inc
TickerMED
Kmenové akcie:Ordinary Shares
RICMED
ISIN-
Prioritní akciePreference Shares Series C
Prioritní akciePreference Shares Series B
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky30.06.2024
Počet zaměstnanců k 31.12.2023 634
Akcie v oběhu k 29.07.2024 10 937 418
MěnaUSD
Kontaktní informace
Ulice11445 Cronhill Dr
MěstoOWINGS MILLS
PSČ21117-2270
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon17 327 640 619
Fax14105818070

Business Summary: Medifast, Inc. is a health and wellness company. The Company provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support. Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders. Its operations are conducted through its subsidiaries.
Financial Summary: BRIEF: For the six months ended 30 June 2024, Medifast Inc revenues decreased 47% to $343.3M. Net income decreased 100% to $162K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Other expense increase from $52K to $1.6M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from $6.46 to $0.02.
Odvětvová klasifikace
TRBC2012Special Foods & Wellbeing Products
RBSS2004Pharmaceuticals - Generic & Specialty
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSMedicinal and Botanical Manufacturing
NAICSPharmaceutical Preparation Manufacturing
NAICS2007Medicinal & Botanical Mfg
NAICS2007Pharmaceutical Preparation Mfg
NAICS1997Medicinal and Botanical Manufacturing
NAICS1997Pharmaceutical Preparation Manufacturing
SICMedicinals And Botanicals
SICPharmaceutical Preparations



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive OfficerDaniel Chard5810.12.202003.10.2016
Chief Financial OfficerJames Maloney5613.09.202120.07.2020
Executive Vice President, General Counsel, Corporate SecretaryJason Groves5317.06.201517.11.2011
Executive Vice President - Human ResourcesClaudia Greninger5101.10.201901.10.2019
Chief Accounting Officer, Vice President - FinanceJonathan Mackenzie5313.09.202113.09.2021
Chief Marketing Officer, Chief Business OperationsAnthony Tyree59
Chief Field Operations OfficerNicholas Johnson44